Enhabit, Inc. (EHAB) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $13.74 (0.00%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 22, 2026 | Michael Wiederhorn | Oppenheimer | $14.00 | +1.9% |
| Dec 9, 2024 | Brian Tanquilut | Jefferies | $9.50 | -30.9% |
| May 14, 2024 | Whit Mayo | Leerink Partners | $8.50 | -38.1% |
Top Analysts Covering EHAB
EHAB vs Sector & Market
| Metric | EHAB | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.57 | 2.24 | 2.41 |
| Analyst Count | 7 | 8 | 18 |
| Target Upside | -1.5% | +1150.3% | +14.9% |
| P/E Ratio | -151.55 | 7.01 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $269M | $274M | $279M | 4 |
| 2026-09-30 | $270M | $277M | $282M | 2 |
| 2026-12-31 | $276M | $283M | $288M | 3 |
| 2027-03-31 | $267M | $274M | $279M | 3 |
| 2027-06-30 | $274M | $281M | $286M | 2 |
| 2027-09-30 | $280M | $287M | $292M | 2 |
| 2027-12-31 | $290M | $298M | $303M | 3 |
| 2028-12-31 | $1.13B | $1.15B | $1.17B | 2 |
| 2029-12-31 | $1.30B | $1.34B | $1.36B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.13 | $0.14 | $0.14 | 3 |
| 2026-09-30 | $0.15 | $0.16 | $0.16 | 1 |
| 2026-12-31 | $0.17 | $0.17 | $0.18 | 1 |
| 2027-03-31 | $0.14 | $0.14 | $0.14 | 1 |
| 2027-06-30 | $0.14 | $0.14 | $0.14 | 1 |
| 2027-09-30 | $0.15 | $0.16 | $0.16 | 1 |
| 2027-12-31 | $0.16 | $0.17 | $0.17 | 1 |
| 2028-12-31 | $0.50 | $0.62 | $0.74 | 2 |
| 2029-12-31 | $0.29 | $0.30 | $0.31 | 1 |
Frequently Asked Questions
What is the analyst consensus for EHAB?
The consensus among 7 analysts covering Enhabit, Inc. (EHAB) is Hold with an average price target of $13.53.
What is the highest price target for EHAB?
The highest price target for EHAB is $14.00, set by Michael Wiederhorn at Oppenheimer on 2026-01-22.
What is the lowest price target for EHAB?
The lowest price target for EHAB is $8.50, set by Whit Mayo at Leerink Partners on 2024-05-14.
How many analysts cover EHAB?
7 analysts have issued ratings for Enhabit, Inc. in the past 12 months.
Is EHAB a buy or sell right now?
Based on 7 analyst ratings, EHAB has a consensus rating of Hold (2.57/5) with a -1.5% upside to the consensus target of $13.53.
What are the earnings estimates for EHAB?
Analysts estimate EHAB will report EPS of $0.14 for the period ending 2026-06-30, with revenue estimated at $274M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.